DJIA 16,934.64 15.05 0.09%
NASDAQ 4,521.11 -6.41 -0.14%
S&P 500 1,982.74 1.14 0.06%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Galena Biopharma, Dr. Reddy's Sign NeuVax Licensing Pact for India

Dr. Reddy's Laboratories will hold the commercial rights for Galena's NeuVax, and head the development of the drug to treat gastric cancer.

Post-TEVA Deal, ANIP Shares Rise - Analyst Blog

Post-TEVA Deal, ANIP Shares Rise - Analyst Blog

Actavis' Women Health Biz Update - Analyst Blog

Zacks' Bear Of The Day: Magellan Health Services

Bull of the Day: Doctor Reddy's Laboratories (RDY) - Bull of the Day

Zacks #1 Rank Additions for Monday - Tale of the Tape

Eli Lilly Sees Generic Competition for Cymbalta (x6)

Dr. Reddy's Laboratories, Teva Pharmaceuticals, and others gain FDA approval for generic versions of Eli Lilly's Cymbalta.

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio

Dr. Reddy's Beats on Earnings - Analyst Blog

Dr. Reddy's Beats on Earnings - Analyst Blog

Dr. Reddy's Laboratories Management Discusses Q2 2014 Results - Earnings Call Transcript